id	sid	tid	token	lemma	pos
cord-294438-btuxeq7o	1	1	key	key	JJ
cord-294438-btuxeq7o	1	2	:	:	:
cord-294438-btuxeq7o	1	3	cord-294438-btuxeq7o	cord-294438-btuxeq7o	JJ
cord-294438-btuxeq7o	1	4	authors	author	NNS
cord-294438-btuxeq7o	1	5	:	:	:
cord-294438-btuxeq7o	1	6	Peng	Peng	NNP
cord-294438-btuxeq7o	1	7	,	,	,
cord-294438-btuxeq7o	1	8	Ling	Ling	NNP
cord-294438-btuxeq7o	1	9	;	;	:
cord-294438-btuxeq7o	1	10	Zagorac	Zagorac	NNP
cord-294438-btuxeq7o	1	11	,	,	,
cord-294438-btuxeq7o	1	12	Sladjana	Sladjana	NNP
cord-294438-btuxeq7o	1	13	;	;	:
cord-294438-btuxeq7o	1	14	Stebbing	Stebbing	NNP
cord-294438-btuxeq7o	1	15	,	,	,
cord-294438-btuxeq7o	1	16	Justin	Justin	NNP
cord-294438-btuxeq7o	1	17	title	title	NN
cord-294438-btuxeq7o	1	18	:	:	:
cord-294438-btuxeq7o	1	19	Managing	manage	VBG
cord-294438-btuxeq7o	1	20	patients	patient	NNS
cord-294438-btuxeq7o	1	21	with	with	IN
cord-294438-btuxeq7o	1	22	cancer	cancer	NN
cord-294438-btuxeq7o	1	23	in	in	IN
cord-294438-btuxeq7o	1	24	the	the	DT
cord-294438-btuxeq7o	1	25	COVID-19	covid-19	JJ
cord-294438-btuxeq7o	1	26	era	era	NN
cord-294438-btuxeq7o	1	27	date	date	NN
cord-294438-btuxeq7o	1	28	:	:	:
cord-294438-btuxeq7o	1	29	2020	2020	CD
cord-294438-btuxeq7o	1	30	-	-	HYPH
cord-294438-btuxeq7o	1	31	06	06	CD
cord-294438-btuxeq7o	1	32	-	-	SYM
cord-294438-btuxeq7o	1	33	30	30	CD
cord-294438-btuxeq7o	1	34	journal	journal	NN
cord-294438-btuxeq7o	1	35	:	:	:
cord-294438-btuxeq7o	1	36	European	European	NNP
cord-294438-btuxeq7o	1	37	Journal	Journal	NNP
cord-294438-btuxeq7o	1	38	of	of	IN
cord-294438-btuxeq7o	1	39	Cancer	Cancer	NNP
cord-294438-btuxeq7o	1	40	DOI	DOI	NNP
cord-294438-btuxeq7o	1	41	:	:	:
cord-294438-btuxeq7o	1	42	10.1016	10.1016	CD
cord-294438-btuxeq7o	1	43	/	/	SYM
cord-294438-btuxeq7o	1	44	j.ejca.2020.03.028	j.ejca.2020.03.028	UH
cord-294438-btuxeq7o	1	45	sha	sha	NNP
cord-294438-btuxeq7o	1	46	:	:	:
cord-294438-btuxeq7o	2	1	60a96220aaf3fbe0cd27e8ad20551712939d2e5e	60a96220aaf3fbe0cd27e8ad20551712939d2e5e	CD
cord-294438-btuxeq7o	2	2	doc_id	doc_id	CD
cord-294438-btuxeq7o	2	3	:	:	:
cord-294438-btuxeq7o	3	1	294438	294438	CD
cord-294438-btuxeq7o	3	2	cord_uid	cord_uid	NNS
cord-294438-btuxeq7o	3	3	:	:	:
cord-294438-btuxeq7o	4	1	btuxeq7o	btuxeq7o	NNP
cord-294438-btuxeq7o	5	1	nan	nan	NNP
cord-294438-btuxeq7o	5	2	There	there	EX
cord-294438-btuxeq7o	5	3	are	be	VBP
cord-294438-btuxeq7o	5	4	an	an	DT
cord-294438-btuxeq7o	5	5	enormous	enormous	JJ
cord-294438-btuxeq7o	5	6	number	number	NN
cord-294438-btuxeq7o	5	7	of	of	IN
cord-294438-btuxeq7o	5	8	unknowns	unknown	NNS
cord-294438-btuxeq7o	5	9	in	in	IN
cord-294438-btuxeq7o	5	10	the	the	DT
cord-294438-btuxeq7o	5	11	management	management	NN
cord-294438-btuxeq7o	5	12	of	of	IN
cord-294438-btuxeq7o	5	13	individuals	individual	NNS
cord-294438-btuxeq7o	5	14	with	with	IN
cord-294438-btuxeq7o	5	15	cancer	cancer	NN
cord-294438-btuxeq7o	5	16	who	who	WP
cord-294438-btuxeq7o	5	17	may	may	MD
cord-294438-btuxeq7o	5	18	be	be	VB
cord-294438-btuxeq7o	5	19	at	at	IN
cord-294438-btuxeq7o	5	20	risk	risk	NN
cord-294438-btuxeq7o	5	21	,	,	,
cord-294438-btuxeq7o	5	22	or	or	CC
cord-294438-btuxeq7o	5	23	may	may	MD
cord-294438-btuxeq7o	5	24	in	in	IN
cord-294438-btuxeq7o	5	25	fact	fact	NN
cord-294438-btuxeq7o	5	26	be	be	VB
cord-294438-btuxeq7o	5	27	infected	infect	VBN
cord-294438-btuxeq7o	5	28	with	with	IN
cord-294438-btuxeq7o	5	29	SARS	SARS	NNP
cord-294438-btuxeq7o	5	30	-	-	HYPH
cord-294438-btuxeq7o	5	31	CoV-2	CoV-2	NNP
cord-294438-btuxeq7o	5	32	.	.	.
cord-294438-btuxeq7o	6	1	In	in	IN
cord-294438-btuxeq7o	6	2	such	such	PDT
cord-294438-btuxeq7o	6	3	a	a	DT
cord-294438-btuxeq7o	6	4	setting	setting	NN
cord-294438-btuxeq7o	6	5	,	,	,
cord-294438-btuxeq7o	6	6	treatment	treatment	NN
cord-294438-btuxeq7o	6	7	decisions	decision	NNS
cord-294438-btuxeq7o	6	8	need	need	VBP
cord-294438-btuxeq7o	6	9	to	to	TO
cord-294438-btuxeq7o	6	10	be	be	VB
cord-294438-btuxeq7o	6	11	made	make	VBN
cord-294438-btuxeq7o	6	12	on	on	IN
cord-294438-btuxeq7o	6	13	a	a	DT
cord-294438-btuxeq7o	6	14	case	case	NN
cord-294438-btuxeq7o	6	15	-	-	HYPH
cord-294438-btuxeq7o	6	16	by	by	IN
cord-294438-btuxeq7o	6	17	-	-	HYPH
cord-294438-btuxeq7o	6	18	case	case	NN
cord-294438-btuxeq7o	6	19	basis	basis	NN
cord-294438-btuxeq7o	6	20	and	and	CC
cord-294438-btuxeq7o	6	21	patient	patient	JJ
cord-294438-btuxeq7o	6	22	stratification	stratification	NN
cord-294438-btuxeq7o	6	23	is	be	VBZ
cord-294438-btuxeq7o	6	24	needed	need	VBN
cord-294438-btuxeq7o	6	25	considering	consider	VBG
cord-294438-btuxeq7o	6	26	the	the	DT
cord-294438-btuxeq7o	6	27	prevailing	prevail	VBG
cord-294438-btuxeq7o	6	28	situation	situation	NN
cord-294438-btuxeq7o	6	29	.	.	.
cord-294438-btuxeq7o	7	1	Our	-PRON-	PRP$
cord-294438-btuxeq7o	7	2	evidence	evidence	NN
cord-294438-btuxeq7o	7	3	to	to	IN
cord-294438-btuxeq7o	7	4	date	date	NN
cord-294438-btuxeq7o	7	5	,	,	,
cord-294438-btuxeq7o	7	6	which	which	WDT
cord-294438-btuxeq7o	7	7	rely	rely	VBP
cord-294438-btuxeq7o	7	8	on	on	IN
cord-294438-btuxeq7o	7	9	our	-PRON-	PRP$
cord-294438-btuxeq7o	7	10	anecdotal	anecdotal	JJ
cord-294438-btuxeq7o	7	11	experiences	experience	NNS
cord-294438-btuxeq7o	7	12	,	,	,
cord-294438-btuxeq7o	7	13	suggests	suggest	VBZ
cord-294438-btuxeq7o	7	14	that	that	IN
cord-294438-btuxeq7o	7	15	the	the	DT
cord-294438-btuxeq7o	7	16	vast	vast	JJ
cord-294438-btuxeq7o	7	17	majority	majority	NN
cord-294438-btuxeq7o	7	18	of	of	IN
cord-294438-btuxeq7o	7	19	patients	patient	NNS
cord-294438-btuxeq7o	7	20	with	with	IN
cord-294438-btuxeq7o	7	21	cancer	cancer	NN
cord-294438-btuxeq7o	7	22	are	be	VBP
cord-294438-btuxeq7o	7	23	concerned	concerned	JJ
cord-294438-btuxeq7o	7	24	about	about	IN
cord-294438-btuxeq7o	7	25	contracting	contract	VBG
cord-294438-btuxeq7o	7	26	COVID-19	covid-19	VB
cord-294438-btuxeq7o	7	27	and	and	CC
cord-294438-btuxeq7o	7	28	ask	ask	VB
cord-294438-btuxeq7o	7	29	both	both	CC
cord-294438-btuxeq7o	7	30	us	-PRON-	PRP
cord-294438-btuxeq7o	7	31	and	and	CC
cord-294438-btuxeq7o	7	32	our	-PRON-	PRP$
cord-294438-btuxeq7o	7	33	colleagues	colleague	NNS
cord-294438-btuxeq7o	7	34	for	for	IN
cord-294438-btuxeq7o	7	35	advice	advice	NN
cord-294438-btuxeq7o	7	36	.	.	.
cord-294438-btuxeq7o	8	1	This	this	DT
cord-294438-btuxeq7o	8	2	is	be	VBZ
cord-294438-btuxeq7o	8	3	occurring	occur	VBG
cord-294438-btuxeq7o	8	4	at	at	IN
cord-294438-btuxeq7o	8	5	a	a	DT
cord-294438-btuxeq7o	8	6	time	time	NN
cord-294438-btuxeq7o	8	7	when	when	WRB
cord-294438-btuxeq7o	8	8	hospital	hospital	NN
cord-294438-btuxeq7o	8	9	attention	attention	NN
cord-294438-btuxeq7o	8	10	is	be	VBZ
cord-294438-btuxeq7o	8	11	understandably	understandably	RB
cord-294438-btuxeq7o	8	12	diverted	divert	VBN
cord-294438-btuxeq7o	8	13	away	away	RB
cord-294438-btuxeq7o	8	14	from	from	IN
cord-294438-btuxeq7o	8	15	planned	plan	VBN
cord-294438-btuxeq7o	8	16	,	,	,
cord-294438-btuxeq7o	8	17	elective	elective	JJ
cord-294438-btuxeq7o	8	18	care	care	NN
cord-294438-btuxeq7o	8	19	,	,	,
cord-294438-btuxeq7o	8	20	and	and	CC
cord-294438-btuxeq7o	8	21	such	such	JJ
cord-294438-btuxeq7o	8	22	individuals	individual	NNS
cord-294438-btuxeq7o	8	23	are	be	VBP
cord-294438-btuxeq7o	8	24	increasingly	increasingly	RB
cord-294438-btuxeq7o	8	25	scared	scared	JJ
cord-294438-btuxeq7o	8	26	to	to	TO
cord-294438-btuxeq7o	8	27	come	come	VB
cord-294438-btuxeq7o	8	28	to	to	IN
cord-294438-btuxeq7o	8	29	hospitals	hospital	NNS
cord-294438-btuxeq7o	8	30	,	,	,
cord-294438-btuxeq7o	8	31	regarded	regard	VBN
cord-294438-btuxeq7o	8	32	understandably	understandably	RB
cord-294438-btuxeq7o	8	33	as	as	IN
cord-294438-btuxeq7o	8	34	infection	infection	NN
cord-294438-btuxeq7o	8	35	epicentres	epicentre	NNS
cord-294438-btuxeq7o	8	36	.	.	.
cord-294438-btuxeq7o	9	1	Liang	Liang	NNP
cord-294438-btuxeq7o	9	2	et	et	NNP
cord-294438-btuxeq7o	9	3	al	al	NNP
cord-294438-btuxeq7o	9	4	.	.	.
cord-294438-btuxeq7o	10	1	[	[	-LRB-
cord-294438-btuxeq7o	10	2	1	1	CD
cord-294438-btuxeq7o	10	3	]	]	-RRB-
cord-294438-btuxeq7o	10	4	reported	report	VBD
cord-294438-btuxeq7o	10	5	patients	patient	NNS
cord-294438-btuxeq7o	10	6	with	with	IN
cord-294438-btuxeq7o	10	7	cancer	cancer	NN
cord-294438-btuxeq7o	10	8	have	have	VBP
cord-294438-btuxeq7o	10	9	a	a	DT
cord-294438-btuxeq7o	10	10	higher	high	JJR
cord-294438-btuxeq7o	10	11	likelihood	likelihood	NN
cord-294438-btuxeq7o	10	12	of	of	IN
cord-294438-btuxeq7o	10	13	being	be	VBG
cord-294438-btuxeq7o	10	14	infected	infect	VBN
cord-294438-btuxeq7o	10	15	,	,	,
cord-294438-btuxeq7o	10	16	but	but	CC
cord-294438-btuxeq7o	10	17	our	-PRON-	PRP$
cord-294438-btuxeq7o	10	18	view	view	NN
cord-294438-btuxeq7o	10	19	is	be	VBZ
cord-294438-btuxeq7o	10	20	that	that	IN
cord-294438-btuxeq7o	10	21	these	these	DT
cord-294438-btuxeq7o	10	22	data	datum	NNS
cord-294438-btuxeq7o	10	23	are	be	VBP
cord-294438-btuxeq7o	10	24	insufficient	insufficient	JJ
cord-294438-btuxeq7o	10	25	to	to	TO
cord-294438-btuxeq7o	10	26	conclude	conclude	VB
cord-294438-btuxeq7o	10	27	that	that	IN
cord-294438-btuxeq7o	10	28	patients	patient	NNS
cord-294438-btuxeq7o	10	29	with	with	IN
cord-294438-btuxeq7o	10	30	cancer	cancer	NN
cord-294438-btuxeq7o	10	31	have	have	VBP
cord-294438-btuxeq7o	10	32	a	a	DT
cord-294438-btuxeq7o	10	33	higher	high	JJR
cord-294438-btuxeq7o	10	34	risk	risk	NN
cord-294438-btuxeq7o	10	35	,	,	,
cord-294438-btuxeq7o	10	36	the	the	DT
cord-294438-btuxeq7o	10	37	reported	report	VBN
cord-294438-btuxeq7o	10	38	sample	sample	NN
cord-294438-btuxeq7o	10	39	size	size	NN
cord-294438-btuxeq7o	10	40	being	be	VBG
cord-294438-btuxeq7o	10	41	too	too	RB
cord-294438-btuxeq7o	10	42	small	small	JJ
cord-294438-btuxeq7o	10	43	and	and	CC
cord-294438-btuxeq7o	10	44	heterogenous	heterogenous	JJ
cord-294438-btuxeq7o	10	45	to	to	TO
cord-294438-btuxeq7o	10	46	draw	draw	VB
cord-294438-btuxeq7o	10	47	such	such	JJ
cord-294438-btuxeq7o	10	48	conclusions	conclusion	NNS
cord-294438-btuxeq7o	10	49	.	.	.
cord-294438-btuxeq7o	11	1	Thus	thus	RB
cord-294438-btuxeq7o	11	2	far	far	RB
cord-294438-btuxeq7o	11	3	,	,	,
cord-294438-btuxeq7o	11	4	the	the	DT
cord-294438-btuxeq7o	11	5	majority	majority	NN
cord-294438-btuxeq7o	11	6	of	of	IN
cord-294438-btuxeq7o	11	7	confirmed	confirm	VBN
cord-294438-btuxeq7o	11	8	COVID-19	covid-19	CD
cord-294438-btuxeq7o	11	9	cases	case	NNS
cord-294438-btuxeq7o	11	10	are	be	VBP
cord-294438-btuxeq7o	11	11	mild	mild	JJ
cord-294438-btuxeq7o	11	12	and	and	CC
cord-294438-btuxeq7o	11	13	the	the	DT
cord-294438-btuxeq7o	11	14	limited	limited	JJ
cord-294438-btuxeq7o	11	15	evidence	evidence	NN
cord-294438-btuxeq7o	11	16	from	from	IN
cord-294438-btuxeq7o	11	17	China	China	NNP
cord-294438-btuxeq7o	11	18	and	and	CC
cord-294438-btuxeq7o	11	19	elsewhere	elsewhere	RB
cord-294438-btuxeq7o	11	20	suggests	suggest	VBZ
cord-294438-btuxeq7o	11	21	that	that	IN
cord-294438-btuxeq7o	11	22	there	there	EX
cord-294438-btuxeq7o	11	23	are	be	VBP
cord-294438-btuxeq7o	11	24	no	no	DT
cord-294438-btuxeq7o	11	25	particular	particular	JJ
cord-294438-btuxeq7o	11	26	steps	step	NNS
cord-294438-btuxeq7o	11	27	that	that	WDT
cord-294438-btuxeq7o	11	28	people	people	NNS
cord-294438-btuxeq7o	11	29	with	with	IN
cord-294438-btuxeq7o	11	30	cancer	cancer	NN
cord-294438-btuxeq7o	11	31	should	should	MD
cord-294438-btuxeq7o	11	32	take	take	VB
cord-294438-btuxeq7o	11	33	to	to	TO
cord-294438-btuxeq7o	11	34	protect	protect	VB
cord-294438-btuxeq7o	11	35	themselves	-PRON-	PRP
cord-294438-btuxeq7o	11	36	although	although	IN
cord-294438-btuxeq7o	11	37	they	-PRON-	PRP
cord-294438-btuxeq7o	11	38	are	be	VBP
cord-294438-btuxeq7o	11	39	clearly	clearly	RB
cord-294438-btuxeq7o	11	40	at	at	IN
cord-294438-btuxeq7o	11	41	risk	risk	NN
cord-294438-btuxeq7o	11	42	,	,	,
cord-294438-btuxeq7o	11	43	often	often	RB
cord-294438-btuxeq7o	11	44	being	be	VBG
cord-294438-btuxeq7o	11	45	older	old	JJR
cord-294438-btuxeq7o	11	46	.	.	.
cord-294438-btuxeq7o	12	1	Although	although	IN
cord-294438-btuxeq7o	12	2	there	there	EX
cord-294438-btuxeq7o	12	3	are	be	VBP
cord-294438-btuxeq7o	12	4	specific	specific	JJ
cord-294438-btuxeq7o	12	5	issues	issue	NNS
cord-294438-btuxeq7o	12	6	,	,	,
cord-294438-btuxeq7o	12	7	for	for	IN
cord-294438-btuxeq7o	12	8	example	example	NN
cord-294438-btuxeq7o	12	9	,	,	,
cord-294438-btuxeq7o	12	10	the	the	DT
cord-294438-btuxeq7o	12	11	radiologic	radiologic	JJ
cord-294438-btuxeq7o	12	12	manifestations	manifestation	NNS
cord-294438-btuxeq7o	12	13	of	of	IN
cord-294438-btuxeq7o	12	14	COVID-19	covid-19	JJ
cord-294438-btuxeq7o	12	15	pneumonia	pneumonia	NN
cord-294438-btuxeq7o	12	16	are	be	VBP
cord-294438-btuxeq7o	12	17	similar	similar	JJ
cord-294438-btuxeq7o	12	18	in	in	IN
cord-294438-btuxeq7o	12	19	some	some	DT
cord-294438-btuxeq7o	12	20	cases	case	NNS
cord-294438-btuxeq7o	12	21	to	to	IN
cord-294438-btuxeq7o	12	22	pneumonitis	pneumonitis	NN
cord-294438-btuxeq7o	12	23	caused	cause	VBN
cord-294438-btuxeq7o	12	24	by	by	IN
cord-294438-btuxeq7o	12	25	checkpoint	checkpoint	NN
cord-294438-btuxeq7o	12	26	inhibitors	inhibitor	NNS
cord-294438-btuxeq7o	12	27	[	[	-LRB-
cord-294438-btuxeq7o	12	28	2	2	CD
cord-294438-btuxeq7o	12	29	]	]	-RRB-
cord-294438-btuxeq7o	12	30	,	,	.
cord-294438-btuxeq7o	13	1	the	the	DT
cord-294438-btuxeq7o	13	2	main	main	JJ
cord-294438-btuxeq7o	13	3	concern	concern	NN
cord-294438-btuxeq7o	13	4	we	-PRON-	PRP
cord-294438-btuxeq7o	13	5	have	have	VBP
cord-294438-btuxeq7o	13	6	is	be	VBZ
cord-294438-btuxeq7o	13	7	that	that	IN
cord-294438-btuxeq7o	13	8	once	once	RB
cord-294438-btuxeq7o	13	9	infected	infect	VBN
cord-294438-btuxeq7o	13	10	,	,	,
cord-294438-btuxeq7o	13	11	patients	patient	NNS
cord-294438-btuxeq7o	13	12	with	with	IN
cord-294438-btuxeq7o	13	13	cancer	cancer	NN
cord-294438-btuxeq7o	13	14	may	may	MD
cord-294438-btuxeq7o	13	15	be	be	VB
cord-294438-btuxeq7o	13	16	at	at	IN
cord-294438-btuxeq7o	13	17	higher	high	JJR
cord-294438-btuxeq7o	13	18	risk	risk	NN
cord-294438-btuxeq7o	13	19	for	for	IN
cord-294438-btuxeq7o	13	20	the	the	DT
cord-294438-btuxeq7o	13	21	more	more	RBR
cord-294438-btuxeq7o	13	22	severe	severe	JJ
cord-294438-btuxeq7o	13	23	form	form	NN
cord-294438-btuxeq7o	13	24	of	of	IN
cord-294438-btuxeq7o	13	25	COVID-19	covid-19	NN
cord-294438-btuxeq7o	13	26	requiring	require	VBG
cord-294438-btuxeq7o	13	27	intensive	intensive	JJ
cord-294438-btuxeq7o	13	28	care	care	NN
cord-294438-btuxeq7o	13	29	treatment	treatment	NN
cord-294438-btuxeq7o	13	30	[	[	-LRB-
cord-294438-btuxeq7o	13	31	1	1	CD
cord-294438-btuxeq7o	13	32	]	]	-RRB-
cord-294438-btuxeq7o	13	33	.	.	.
cord-294438-btuxeq7o	14	1	Thus	thus	RB
cord-294438-btuxeq7o	14	2	,	,	,
cord-294438-btuxeq7o	14	3	for	for	IN
cord-294438-btuxeq7o	14	4	those	those	DT
cord-294438-btuxeq7o	14	5	infected	infect	VBN
cord-294438-btuxeq7o	14	6	,	,	,
cord-294438-btuxeq7o	14	7	it	-PRON-	PRP
cord-294438-btuxeq7o	14	8	seems	seem	VBZ
cord-294438-btuxeq7o	14	9	reasonable	reasonable	JJ
cord-294438-btuxeq7o	14	10	to	to	TO
cord-294438-btuxeq7o	14	11	suggest	suggest	VB
cord-294438-btuxeq7o	14	12	that	that	IN
cord-294438-btuxeq7o	14	13	regular	regular	JJ
cord-294438-btuxeq7o	14	14	surveillance	surveillance	NN
cord-294438-btuxeq7o	14	15	including	include	VBG
cord-294438-btuxeq7o	14	16	monitoring	monitor	VBG
cord-294438-btuxeq7o	14	17	oxygen	oxygen	NN
cord-294438-btuxeq7o	14	18	saturations	saturation	NNS
cord-294438-btuxeq7o	14	19	should	should	MD
cord-294438-btuxeq7o	14	20	be	be	VB
cord-294438-btuxeq7o	14	21	provided	provide	VBN
cord-294438-btuxeq7o	14	22	and	and	CC
cord-294438-btuxeq7o	14	23	perhaps	perhaps	RB
cord-294438-btuxeq7o	14	24	if	if	IN
cord-294438-btuxeq7o	14	25	an	an	DT
cord-294438-btuxeq7o	14	26	infection	infection	NN
cord-294438-btuxeq7o	14	27	occurs	occur	VBZ
cord-294438-btuxeq7o	14	28	during	during	IN
cord-294438-btuxeq7o	14	29	chemotherapyinduced	chemotherapyinduced	JJ
cord-294438-btuxeq7o	14	30	neutropenia	neutropenia	NN
cord-294438-btuxeq7o	14	31	,	,	,
cord-294438-btuxeq7o	14	32	hospital	hospital	NN
cord-294438-btuxeq7o	14	33	admission	admission	NN
cord-294438-btuxeq7o	14	34	would	would	MD
cord-294438-btuxeq7o	14	35	seem	seem	VB
cord-294438-btuxeq7o	14	36	appropriate	appropriate	JJ
cord-294438-btuxeq7o	14	37	.	.	.
cord-294438-btuxeq7o	15	1	Whether	whether	IN
cord-294438-btuxeq7o	15	2	patients	patient	NNS
cord-294438-btuxeq7o	15	3	who	who	WP
cord-294438-btuxeq7o	15	4	have	have	VBP
cord-294438-btuxeq7o	15	5	confirmed	confirm	VBN
cord-294438-btuxeq7o	15	6	COVID-19	covid-19	CD
cord-294438-btuxeq7o	15	7	infection	infection	NN
cord-294438-btuxeq7o	15	8	should	should	MD
cord-294438-btuxeq7o	15	9	stop	stop	VB
cord-294438-btuxeq7o	15	10	their	-PRON-	PRP$
cord-294438-btuxeq7o	15	11	anti	anti	JJ
cord-294438-btuxeq7o	15	12	-	-	JJ
cord-294438-btuxeq7o	15	13	cancer	cancer	JJ
cord-294438-btuxeq7o	15	14	therapy	therapy	NN
cord-294438-btuxeq7o	15	15	or	or	CC
cord-294438-btuxeq7o	15	16	not	not	RB
cord-294438-btuxeq7o	15	17	remains	remain	VBZ
cord-294438-btuxeq7o	15	18	debated	debate	VBN
cord-294438-btuxeq7o	15	19	;	;	:
cord-294438-btuxeq7o	15	20	one	one	CD
cord-294438-btuxeq7o	15	21	reported	report	VBN
cord-294438-btuxeq7o	15	22	patient	patient	NN
cord-294438-btuxeq7o	15	23	with	with	IN
cord-294438-btuxeq7o	15	24	lung	lung	NN
cord-294438-btuxeq7o	15	25	cancer	cancer	NN
cord-294438-btuxeq7o	15	26	diagnosed	diagnose	VBN
cord-294438-btuxeq7o	15	27	with	with	IN
cord-294438-btuxeq7o	15	28	COVID-19	COVID-19	NNP
cord-294438-btuxeq7o	15	29	continued	continue	VBN
cord-294438-btuxeq7o	15	30	targeted	target	VBN
cord-294438-btuxeq7o	15	31	therapy	therapy	NN
cord-294438-btuxeq7o	15	32	during	during	IN
cord-294438-btuxeq7o	15	33	the	the	DT
cord-294438-btuxeq7o	15	34	course	course	NN
cord-294438-btuxeq7o	15	35	of	of	IN
cord-294438-btuxeq7o	15	36	virus	virus	NN
cord-294438-btuxeq7o	15	37	infection	infection	NN
cord-294438-btuxeq7o	15	38	[	[	-LRB-
cord-294438-btuxeq7o	15	39	3	3	CD
cord-294438-btuxeq7o	15	40	]	]	-RRB-
cord-294438-btuxeq7o	15	41	.	.	.
cord-294438-btuxeq7o	16	1	Intriguingly	intriguingly	RB
cord-294438-btuxeq7o	16	2	,	,	,
cord-294438-btuxeq7o	16	3	patients	patient	NNS
cord-294438-btuxeq7o	16	4	with	with	IN
cord-294438-btuxeq7o	16	5	cancer	cancer	NN
cord-294438-btuxeq7o	16	6	co	co	NNS
cord-294438-btuxeq7o	16	7	-	-	VBN
cord-294438-btuxeq7o	16	8	infected	infect	VBN
cord-294438-btuxeq7o	16	9	with	with	IN
cord-294438-btuxeq7o	16	10	HIV-1	HIV-1	NNP
cord-294438-btuxeq7o	16	11	and	and	CC
cord-294438-btuxeq7o	16	12	hepatitis	hepatitis	NNP
cord-294438-btuxeq7o	16	13	B	B	NNP
cord-294438-btuxeq7o	16	14	do	do	VB
cord-294438-btuxeq7o	16	15	not	not	RB
cord-294438-btuxeq7o	16	16	have	have	VB
cord-294438-btuxeq7o	16	17	viral	viral	JJ
cord-294438-btuxeq7o	16	18	re	re	NN
cord-294438-btuxeq7o	16	19	-	-	NN
cord-294438-btuxeq7o	16	20	activation	activation	NN
cord-294438-btuxeq7o	16	21	during	during	IN
cord-294438-btuxeq7o	16	22	chemotherapy	chemotherapy	NN
cord-294438-btuxeq7o	16	23	[	[	-LRB-
cord-294438-btuxeq7o	16	24	4	4	CD
cord-294438-btuxeq7o	16	25	]	]	-RRB-
cord-294438-btuxeq7o	16	26	,	,	,
cord-294438-btuxeq7o	16	27	suggesting	suggest	VBG
cord-294438-btuxeq7o	16	28	here	here	RB
cord-294438-btuxeq7o	16	29	that	that	DT
cord-294438-btuxeq7o	16	30	treatment	treatment	NN
cord-294438-btuxeq7o	16	31	does	do	VBZ
cord-294438-btuxeq7o	16	32	not	not	RB
cord-294438-btuxeq7o	16	33	need	need	VB
cord-294438-btuxeq7o	16	34	to	to	TO
cord-294438-btuxeq7o	16	35	stop	stop	VB
cord-294438-btuxeq7o	16	36	,	,	,
cord-294438-btuxeq7o	16	37	although	although	IN
cord-294438-btuxeq7o	16	38	of	of	IN
cord-294438-btuxeq7o	16	39	course	course	NN
cord-294438-btuxeq7o	16	40	,	,	,
cord-294438-btuxeq7o	16	41	data	datum	NNS
cord-294438-btuxeq7o	16	42	may	may	MD
cord-294438-btuxeq7o	16	43	be	be	VB
cord-294438-btuxeq7o	16	44	different	different	JJ
cord-294438-btuxeq7o	16	45	for	for	IN
cord-294438-btuxeq7o	16	46	different	different	JJ
cord-294438-btuxeq7o	16	47	viruses	virus	NNS
cord-294438-btuxeq7o	16	48	and	and	CC
cord-294438-btuxeq7o	16	49	symptoms	symptom	NNS
cord-294438-btuxeq7o	16	50	of	of	IN
cord-294438-btuxeq7o	16	51	COVID-19	COVID-19	NNP
cord-294438-btuxeq7o	16	52	may	may	MD
cord-294438-btuxeq7o	16	53	not	not	RB
cord-294438-btuxeq7o	16	54	correlate	correlate	VB
cord-294438-btuxeq7o	16	55	with	with	IN
cord-294438-btuxeq7o	16	56	SARS	SARS	NNP
cord-294438-btuxeq7o	16	57	-	-	HYPH
cord-294438-btuxeq7o	16	58	CoV-2	CoV-2	NNP
cord-294438-btuxeq7o	16	59	levels	level	NNS
cord-294438-btuxeq7o	16	60	.	.	.
cord-294438-btuxeq7o	17	1	Starting	start	VBG
cord-294438-btuxeq7o	17	2	with	with	IN
cord-294438-btuxeq7o	17	3	its	-PRON-	PRP$
cord-294438-btuxeq7o	17	4	biology	biology	NN
cord-294438-btuxeq7o	17	5	,	,	,
cord-294438-btuxeq7o	17	6	its	-PRON-	PRP$
cord-294438-btuxeq7o	17	7	cellular	cellular	JJ
cord-294438-btuxeq7o	17	8	entry	entry	NN
cord-294438-btuxeq7o	17	9	receptor	receptor	NN
cord-294438-btuxeq7o	17	10	,	,	,
cord-294438-btuxeq7o	17	11	angiotensin	angiotensin	NN
cord-294438-btuxeq7o	17	12	-	-	HYPH
cord-294438-btuxeq7o	17	13	converting	convert	VBG
cord-294438-btuxeq7o	17	14	enzyme	enzyme	NN
cord-294438-btuxeq7o	17	15	2	2	CD
cord-294438-btuxeq7o	17	16	(	(	-LRB-
cord-294438-btuxeq7o	17	17	ACE2	ACE2	NNP
cord-294438-btuxeq7o	17	18	)	)	-RRB-
cord-294438-btuxeq7o	17	19	[	[	-LRB-
cord-294438-btuxeq7o	17	20	5	5	CD
cord-294438-btuxeq7o	17	21	]	]	-RRB-
cord-294438-btuxeq7o	17	22	may	may	MD
cord-294438-btuxeq7o	17	23	be	be	VB
cord-294438-btuxeq7o	17	24	over	over	RB
cord-294438-btuxeq7o	17	25	-	-	HYPH
cord-294438-btuxeq7o	17	26	expressed	express	VBN
cord-294438-btuxeq7o	17	27	on	on	IN
cord-294438-btuxeq7o	17	28	some	some	DT
cord-294438-btuxeq7o	17	29	cancers	cancer	NNS
cord-294438-btuxeq7o	17	30	including	include	VBG
cord-294438-btuxeq7o	17	31	cervical	cervical	JJ
cord-294438-btuxeq7o	17	32	,	,	,
cord-294438-btuxeq7o	17	33	pancreatic	pancreatic	JJ
cord-294438-btuxeq7o	17	34	and	and	CC
cord-294438-btuxeq7o	17	35	renal	renal	JJ
cord-294438-btuxeq7o	17	36	carcinomas	carcinoma	NNS
cord-294438-btuxeq7o	17	37	based	base	VBN
cord-294438-btuxeq7o	17	38	on	on	IN
cord-294438-btuxeq7o	17	39	one	one	CD
cord-294438-btuxeq7o	17	40	study	study	NN
cord-294438-btuxeq7o	17	41	[	[	-LRB-
cord-294438-btuxeq7o	17	42	6	6	CD
cord-294438-btuxeq7o	17	43	]	]	-RRB-
cord-294438-btuxeq7o	17	44	.	.	.
cord-294438-btuxeq7o	18	1	By	by	IN
cord-294438-btuxeq7o	18	2	contrast	contrast	NN
cord-294438-btuxeq7o	18	3	,	,	,
cord-294438-btuxeq7o	18	4	our	-PRON-	PRP$
cord-294438-btuxeq7o	18	5	analysis	analysis	NN
cord-294438-btuxeq7o	18	6	of	of	IN
cord-294438-btuxeq7o	18	7	data	datum	NNS
cord-294438-btuxeq7o	18	8	from	from	IN
cord-294438-btuxeq7o	18	9	TCGA	TCGA	NNP
cord-294438-btuxeq7o	18	10	(	(	-LRB-
cord-294438-btuxeq7o	18	11	Fig	Fig	NNP
cord-294438-btuxeq7o	18	12	.	.	.
cord-294438-btuxeq7o	18	13	1	1	CD
cord-294438-btuxeq7o	18	14	)	)	-RRB-
cord-294438-btuxeq7o	18	15	indicates	indicate	VBZ
cord-294438-btuxeq7o	18	16	expression	expression	NN
cord-294438-btuxeq7o	18	17	of	of	IN
cord-294438-btuxeq7o	18	18	ACE2	ACE2	NNP
cord-294438-btuxeq7o	18	19	to	to	TO
cord-294438-btuxeq7o	18	20	be	be	VB
cord-294438-btuxeq7o	18	21	significantly	significantly	RB
cord-294438-btuxeq7o	18	22	decreased	decrease	VBN
cord-294438-btuxeq7o	18	23	in	in	IN
cord-294438-btuxeq7o	18	24	breast	breast	NN
cord-294438-btuxeq7o	18	25	,	,	,
cord-294438-btuxeq7o	18	26	liver	liver	NN
cord-294438-btuxeq7o	18	27	and	and	CC
cord-294438-btuxeq7o	18	28	prostate	prostate	NN
cord-294438-btuxeq7o	18	29	cancer	cancer	NN
cord-294438-btuxeq7o	18	30	compared	compare	VBN
cord-294438-btuxeq7o	18	31	with	with	IN
cord-294438-btuxeq7o	18	32	normal	normal	JJ
cord-294438-btuxeq7o	18	33	adjacent	adjacent	JJ
cord-294438-btuxeq7o	18	34	tissues	tissue	NNS
cord-294438-btuxeq7o	18	35	.	.	.
cord-294438-btuxeq7o	19	1	The	the	DT
cord-294438-btuxeq7o	19	2	likely	likely	JJ
cord-294438-btuxeq7o	19	3	impact	impact	NN
cord-294438-btuxeq7o	19	4	of	of	IN
cord-294438-btuxeq7o	19	5	the	the	DT
cord-294438-btuxeq7o	19	6	underlying	underlie	VBG
cord-294438-btuxeq7o	19	7	cancer	cancer	NN
cord-294438-btuxeq7o	19	8	varies	vary	VBZ
cord-294438-btuxeq7o	19	9	enormously	enormously	RB
cord-294438-btuxeq7o	19	10	e	e	JJ
cord-294438-btuxeq7o	19	11	from	from	IN
cord-294438-btuxeq7o	19	12	an	an	DT
cord-294438-btuxeq7o	19	13	early	early	JJ
cord-294438-btuxeq7o	19	14	breast	breast	NN
cord-294438-btuxeq7o	19	15	cancer	cancer	NN
cord-294438-btuxeq7o	19	16	to	to	IN
cord-294438-btuxeq7o	19	17	metastatic	metastatic	JJ
cord-294438-btuxeq7o	19	18	lung	lung	NN
cord-294438-btuxeq7o	19	19	cancer	cancer	NN
cord-294438-btuxeq7o	19	20	.	.	.
cord-294438-btuxeq7o	20	1	Many	many	JJ
cord-294438-btuxeq7o	20	2	adjuvant	adjuvant	JJ
cord-294438-btuxeq7o	20	3	patients	patient	NNS
cord-294438-btuxeq7o	20	4	benefit	benefit	VBP
cord-294438-btuxeq7o	20	5	a	a	DT
cord-294438-btuxeq7o	20	6	great	great	JJ
cord-294438-btuxeq7o	20	7	deal	deal	NN
cord-294438-btuxeq7o	20	8	more	more	JJR
cord-294438-btuxeq7o	20	9	than	than	IN
cord-294438-btuxeq7o	20	10	5	5	CD
cord-294438-btuxeq7o	20	11	%	%	NN
cord-294438-btuxeq7o	20	12	,	,	,
cord-294438-btuxeq7o	20	13	as	as	RB
cord-294438-btuxeq7o	20	14	much	much	JJ
cord-294438-btuxeq7o	20	15	as	as	IN
cord-294438-btuxeq7o	20	16	30	30	CD
cord-294438-btuxeq7o	20	17	%	%	NN
cord-294438-btuxeq7o	20	18	in	in	IN
cord-294438-btuxeq7o	20	19	absolute	absolute	JJ
cord-294438-btuxeq7o	20	20	terms	term	NNS
cord-294438-btuxeq7o	20	21	in	in	IN
cord-294438-btuxeq7o	20	22	patients	patient	NNS
cord-294438-btuxeq7o	20	23	with	with	IN
cord-294438-btuxeq7o	20	24	breast	breast	NN
cord-294438-btuxeq7o	20	25	cancer	cancer	NN
cord-294438-btuxeq7o	20	26	at	at	IN
cord-294438-btuxeq7o	20	27	high	high	JJ
cord-294438-btuxeq7o	20	28	risk	risk	NN
cord-294438-btuxeq7o	20	29	,	,	,
cord-294438-btuxeq7o	20	30	for	for	IN
cord-294438-btuxeq7o	20	31	example	example	NN
cord-294438-btuxeq7o	20	32	,	,	,
cord-294438-btuxeq7o	20	33	but	but	CC
cord-294438-btuxeq7o	20	34	there	there	EX
cord-294438-btuxeq7o	20	35	are	be	VBP
cord-294438-btuxeq7o	20	36	no	no	DT
cord-294438-btuxeq7o	20	37	data	data	NN
cord-294438-btuxeq7o	20	38	on	on	IN
cord-294438-btuxeq7o	20	39	who	who	WP
cord-294438-btuxeq7o	20	40	to	to	TO
cord-294438-btuxeq7o	20	41	treat	treat	VB
cord-294438-btuxeq7o	20	42	or	or	CC
cord-294438-btuxeq7o	20	43	not	not	RB
cord-294438-btuxeq7o	20	44	during	during	IN
cord-294438-btuxeq7o	20	45	the	the	DT
cord-294438-btuxeq7o	20	46	pandemic	pandemic	NN
cord-294438-btuxeq7o	20	47	.	.	.
cord-294438-btuxeq7o	21	1	In	in	IN
cord-294438-btuxeq7o	21	2	terms	term	NNS
cord-294438-btuxeq7o	21	3	of	of	IN
cord-294438-btuxeq7o	21	4	risk	risk	NN
cord-294438-btuxeq7o	21	5	,	,	,
cord-294438-btuxeq7o	21	6	there	there	EX
cord-294438-btuxeq7o	21	7	is	be	VBZ
cord-294438-btuxeq7o	21	8	no	no	DT
cord-294438-btuxeq7o	21	9	separate	separate	JJ
cord-294438-btuxeq7o	21	10	hazard	hazard	NN
cord-294438-btuxeq7o	21	11	ratio	ratio	NN
cord-294438-btuxeq7o	21	12	for	for	IN
cord-294438-btuxeq7o	21	13	use	use	NN
cord-294438-btuxeq7o	21	14	of	of	IN
cord-294438-btuxeq7o	21	15	chemotherapy	chemotherapy	NN
cord-294438-btuxeq7o	21	16	as	as	IN
cord-294438-btuxeq7o	21	17	this	this	DT
cord-294438-btuxeq7o	21	18	will	will	MD
cord-294438-btuxeq7o	21	19	be	be	VB
cord-294438-btuxeq7o	21	20	treatment	treatment	NN
cord-294438-btuxeq7o	21	21	(	(	-LRB-
cord-294438-btuxeq7o	21	22	drug	drug	NN
cord-294438-btuxeq7o	21	23	,	,	,
cord-294438-btuxeq7o	21	24	dose	dose	NN
cord-294438-btuxeq7o	21	25	density	density	NN
cord-294438-btuxeq7o	21	26	and	and	CC
cord-294438-btuxeq7o	21	27	frequency	frequency	NN
cord-294438-btuxeq7o	21	28	)	)	-RRB-
cord-294438-btuxeq7o	21	29	,	,	,
cord-294438-btuxeq7o	21	30	host	host	NN
cord-294438-btuxeq7o	21	31	(	(	-LRB-
cord-294438-btuxeq7o	21	32	age	age	NN
cord-294438-btuxeq7o	21	33	,	,	,
cord-294438-btuxeq7o	21	34	perhaps	perhaps	RB
cord-294438-btuxeq7o	21	35	sex	sex	NN
cord-294438-btuxeq7o	21	36	too	too	RB
cord-294438-btuxeq7o	21	37	)	)	-RRB-
cord-294438-btuxeq7o	21	38	,	,	,
cord-294438-btuxeq7o	21	39	intent	intent	JJ
cord-294438-btuxeq7o	21	40	(	(	-LRB-
cord-294438-btuxeq7o	21	41	palliative	palliative	JJ
cord-294438-btuxeq7o	21	42	versus	versus	IN
cord-294438-btuxeq7o	21	43	curative	curative	JJ
cord-294438-btuxeq7o	21	44	)	)	-RRB-
cord-294438-btuxeq7o	21	45	and	and	CC
cord-294438-btuxeq7o	21	46	tumour	tumour	NN
cord-294438-btuxeq7o	21	47	(	(	-LRB-
cord-294438-btuxeq7o	22	1	stage	stage	NN
cord-294438-btuxeq7o	22	2	,	,	,
cord-294438-btuxeq7o	22	3	type	type	NN
cord-294438-btuxeq7o	22	4	)	)	-RRB-
cord-294438-btuxeq7o	22	5	dependent	dependent	JJ
cord-294438-btuxeq7o	22	6	;	;	:
cord-294438-btuxeq7o	22	7	the	the	DT
cord-294438-btuxeq7o	22	8	only	only	JJ
cord-294438-btuxeq7o	22	9	direct	direct	JJ
cord-294438-btuxeq7o	22	10	report	report	NN
cord-294438-btuxeq7o	22	11	is	be	VBZ
cord-294438-btuxeq7o	22	12	threefourth	threefourth	NN
cord-294438-btuxeq7o	22	13	of	of	IN
cord-294438-btuxeq7o	22	14	patients	patient	NNS
cord-294438-btuxeq7o	22	15	receiving	receive	VBG
cord-294438-btuxeq7o	22	16	chemotherapy	chemotherapy	NN
cord-294438-btuxeq7o	22	17	needed	need	VBD
cord-294438-btuxeq7o	22	18	intensive	intensive	JJ
cord-294438-btuxeq7o	22	19	care	care	NN
cord-294438-btuxeq7o	22	20	or	or	CC
cord-294438-btuxeq7o	22	21	died	die	VBN
cord-294438-btuxeq7o	22	22	(	(	-LRB-
cord-294438-btuxeq7o	22	23	but	but	CC
cord-294438-btuxeq7o	22	24	only	only	RB
cord-294438-btuxeq7o	22	25	a	a	DT
cord-294438-btuxeq7o	22	26	sample	sample	NN
cord-294438-btuxeq7o	22	27	of	of	IN
cord-294438-btuxeq7o	22	28	4	4	CD
cord-294438-btuxeq7o	22	29	)	)	-RRB-
cord-294438-btuxeq7o	23	1	[	[	-LRB-
cord-294438-btuxeq7o	23	2	7	7	CD
cord-294438-btuxeq7o	23	3	]	]	-RRB-
cord-294438-btuxeq7o	23	4	.	.	.
cord-294438-btuxeq7o	24	1	Immunotherapy	immunotherapy	NN
cord-294438-btuxeq7o	24	2	has	have	VBZ
cord-294438-btuxeq7o	24	3	clearly	clearly	RB
cord-294438-btuxeq7o	24	4	different	different	JJ
cord-294438-btuxeq7o	24	5	risks	risk	NNS
cord-294438-btuxeq7o	24	6	,	,	,
cord-294438-btuxeq7o	24	7	as	as	IN
cord-294438-btuxeq7o	24	8	does	do	VBZ
cord-294438-btuxeq7o	24	9	underlying	underlie	VBG
cord-294438-btuxeq7o	24	10	co	co	NNS
cord-294438-btuxeq7o	24	11	-	-	NNS
cord-294438-btuxeq7o	24	12	morbidities	morbidity	NNS
cord-294438-btuxeq7o	24	13	,	,	,
cord-294438-btuxeq7o	24	14	notably	notably	RB
cord-294438-btuxeq7o	24	15	hypertension	hypertension	NN
cord-294438-btuxeq7o	24	16	or	or	CC
cord-294438-btuxeq7o	24	17	any	any	DT
cord-294438-btuxeq7o	24	18	pulmonary	pulmonary	JJ
cord-294438-btuxeq7o	24	19	disease	disease	NN
cord-294438-btuxeq7o	24	20	.	.	.
cord-294438-btuxeq7o	25	1	The	the	DT
cord-294438-btuxeq7o	25	2	additional	additional	JJ
cord-294438-btuxeq7o	25	3	effects	effect	NNS
cord-294438-btuxeq7o	25	4	due	due	IN
cord-294438-btuxeq7o	25	5	to	to	IN
cord-294438-btuxeq7o	25	6	bed	bed	NN
cord-294438-btuxeq7o	25	7	capacity	capacity	NN
cord-294438-btuxeq7o	25	8	,	,	,
cord-294438-btuxeq7o	25	9	for	for	IN
cord-294438-btuxeq7o	25	10	example	example	NN
cord-294438-btuxeq7o	25	11	,	,	,
cord-294438-btuxeq7o	25	12	giving	give	VBG
cord-294438-btuxeq7o	25	13	chemotherapy	chemotherapy	NN
cord-294438-btuxeq7o	25	14	when	when	WRB
cord-294438-btuxeq7o	25	15	there	there	EX
cord-294438-btuxeq7o	25	16	is	be	VBZ
cord-294438-btuxeq7o	25	17	no	no	DT
cord-294438-btuxeq7o	25	18	intensive	intensive	JJ
cord-294438-btuxeq7o	25	19	care	care	NN
cord-294438-btuxeq7o	25	20	availability	availability	NN
cord-294438-btuxeq7o	25	21	,	,	,
cord-294438-btuxeq7o	25	22	are	be	VBP
cord-294438-btuxeq7o	25	23	challenging	challenge	VBG
cord-294438-btuxeq7o	25	24	.	.	.
cord-294438-btuxeq7o	26	1	It	-PRON-	PRP
cord-294438-btuxeq7o	26	2	appears	appear	VBZ
cord-294438-btuxeq7o	26	3	that	that	IN
cord-294438-btuxeq7o	26	4	the	the	DT
cord-294438-btuxeq7o	26	5	host	host	NN
cord-294438-btuxeq7o	26	6	response	response	NN
cord-294438-btuxeq7o	26	7	observed	observe	VBD
cord-294438-btuxeq7o	26	8	during	during	IN
cord-294438-btuxeq7o	26	9	infection	infection	NN
cord-294438-btuxeq7o	26	10	that	that	WDT
cord-294438-btuxeq7o	26	11	probably	probably	RB
cord-294438-btuxeq7o	26	12	mediates	mediate	VBZ
cord-294438-btuxeq7o	26	13	much	much	JJ
cord-294438-btuxeq7o	26	14	of	of	IN
cord-294438-btuxeq7o	26	15	its	-PRON-	PRP$
cord-294438-btuxeq7o	26	16	pathogenesis	pathogenesis	NN
cord-294438-btuxeq7o	26	17	[	[	-LRB-
cord-294438-btuxeq7o	26	18	8	8	CD
cord-294438-btuxeq7o	26	19	]	]	-RRB-
cord-294438-btuxeq7o	26	20	analogous	analogous	JJ
cord-294438-btuxeq7o	26	21	to	to	IN
cord-294438-btuxeq7o	26	22	cytokine	cytokine	JJ
cord-294438-btuxeq7o	26	23	storms	storm	NNS
cord-294438-btuxeq7o	26	24	during	during	IN
cord-294438-btuxeq7o	26	25	CAR	car	NN
cord-294438-btuxeq7o	26	26	-	-	HYPH
cord-294438-btuxeq7o	26	27	T	t	NN
cord-294438-btuxeq7o	26	28	therapy	therapy	NN
cord-294438-btuxeq7o	26	29	.	.	.
cord-294438-btuxeq7o	27	1	In	in	IN
cord-294438-btuxeq7o	27	2	patients	patient	NNS
cord-294438-btuxeq7o	27	3	with	with	IN
cord-294438-btuxeq7o	27	4	cancer	cancer	NN
cord-294438-btuxeq7o	27	5	infected	infect	VBN
cord-294438-btuxeq7o	27	6	with	with	IN
cord-294438-btuxeq7o	27	7	SARS-	SARS-	NNP
cord-294438-btuxeq7o	27	8	CoV-2	CoV-2	NNP
cord-294438-btuxeq7o	27	9	,	,	,
cord-294438-btuxeq7o	27	10	inhibiting	inhibit	VBG
cord-294438-btuxeq7o	27	11	excessive	excessive	JJ
cord-294438-btuxeq7o	27	12	immune	immune	JJ
cord-294438-btuxeq7o	27	13	cell	cell	NN
cord-294438-btuxeq7o	27	14	activation	activation	NN
cord-294438-btuxeq7o	27	15	and	and	CC
cord-294438-btuxeq7o	27	16	cytokine	cytokine	NN
cord-294438-btuxeq7o	27	17	production	production	NN
cord-294438-btuxeq7o	27	18	is	be	VBZ
cord-294438-btuxeq7o	27	19	probably	probably	RB
cord-294438-btuxeq7o	27	20	central	central	JJ
cord-294438-btuxeq7o	27	21	,	,	,
cord-294438-btuxeq7o	27	22	although	although	IN
cord-294438-btuxeq7o	27	23	use	use	NN
cord-294438-btuxeq7o	27	24	of	of	IN
cord-294438-btuxeq7o	27	25	corticosteroids	corticosteroid	NNS
cord-294438-btuxeq7o	27	26	is	be	VBZ
cord-294438-btuxeq7o	27	27	controversial	controversial	JJ
cord-294438-btuxeq7o	27	28	[	[	-LRB-
cord-294438-btuxeq7o	27	29	9	9	CD
cord-294438-btuxeq7o	27	30	,	,	,
cord-294438-btuxeq7o	27	31	10	10	CD
cord-294438-btuxeq7o	27	32	]	]	-RRB-
cord-294438-btuxeq7o	27	33	.	.	.
cord-294438-btuxeq7o	28	1	It	-PRON-	PRP
cord-294438-btuxeq7o	28	2	is	be	VBZ
cord-294438-btuxeq7o	28	3	notable	notable	JJ
cord-294438-btuxeq7o	28	4	to	to	IN
cord-294438-btuxeq7o	28	5	us	-PRON-	PRP
cord-294438-btuxeq7o	28	6	that	that	IN
cord-294438-btuxeq7o	28	7	one	one	CD
cord-294438-btuxeq7o	28	8	of	of	IN
cord-294438-btuxeq7o	28	9	the	the	DT
cord-294438-btuxeq7o	28	10	best	good	JJS
cord-294438-btuxeq7o	28	11	prospects	prospect	NNS
cord-294438-btuxeq7o	28	12	for	for	IN
cord-294438-btuxeq7o	28	13	treating	treat	VBG
cord-294438-btuxeq7o	28	14	the	the	DT
cord-294438-btuxeq7o	28	15	virus	virus	NN
cord-294438-btuxeq7o	28	16	modulates	modulate	VBZ
cord-294438-btuxeq7o	28	17	the	the	DT
cord-294438-btuxeq7o	28	18	host	host	NN
cord-294438-btuxeq7o	28	19	immune	immune	JJ
cord-294438-btuxeq7o	28	20	response	response	NN
cord-294438-btuxeq7o	28	21	and	and	CC
cord-294438-btuxeq7o	28	22	is	be	VBZ
cord-294438-btuxeq7o	28	23	useful	useful	JJ
cord-294438-btuxeq7o	28	24	too	too	RB
cord-294438-btuxeq7o	28	25	in	in	IN
cord-294438-btuxeq7o	28	26	treating	treat	VBG
cord-294438-btuxeq7o	28	27	manifestations	manifestation	NNS
cord-294438-btuxeq7o	28	28	of	of	IN
cord-294438-btuxeq7o	28	29	the	the	DT
cord-294438-btuxeq7o	28	30	rare	rare	JJ
cord-294438-btuxeq7o	28	31	cancer	cancer	NN
cord-294438-btuxeq7o	28	32	,	,	,
cord-294438-btuxeq7o	28	33	multicentric	multicentric	NNP
cord-294438-btuxeq7o	28	34	Castleman	Castleman	NNP
cord-294438-btuxeq7o	28	35	's	's	POS
cord-294438-btuxeq7o	28	36	disease	disease	NN
cord-294438-btuxeq7o	28	37	,	,	,
cord-294438-btuxeq7o	28	38	as	as	RB
cord-294438-btuxeq7o	28	39	well	well	RB
cord-294438-btuxeq7o	28	40	as	as	IN
cord-294438-btuxeq7o	28	41	its	-PRON-	PRP$
cord-294438-btuxeq7o	28	42	licenced	licenced	JJ
cord-294438-btuxeq7o	28	43	rheumatoid	rheumatoid	NN
cord-294438-btuxeq7o	28	44	arthritis	arthritis	NN
cord-294438-btuxeq7o	28	45	indication	indication	NN
cord-294438-btuxeq7o	28	46	[	[	-LRB-
cord-294438-btuxeq7o	28	47	11	11	CD
cord-294438-btuxeq7o	28	48	]	]	-RRB-
cord-294438-btuxeq7o	28	49	;	;	:
cord-294438-btuxeq7o	28	50	targeting	target	VBG
cord-294438-btuxeq7o	28	51	the	the	DT
cord-294438-btuxeq7o	28	52	IL-6	IL-6	NNP
cord-294438-btuxeq7o	28	53	pathway	pathway	NN
cord-294438-btuxeq7o	28	54	using	use	VBG
cord-294438-btuxeq7o	28	55	tocilizumab	tocilizumab	NNP
cord-294438-btuxeq7o	28	56	has	have	VBZ
cord-294438-btuxeq7o	28	57	led	lead	VBN
cord-294438-btuxeq7o	28	58	to	to	IN
cord-294438-btuxeq7o	28	59	inclusion	inclusion	NN
cord-294438-btuxeq7o	28	60	in	in	IN
cord-294438-btuxeq7o	28	61	China	China	NNP
cord-294438-btuxeq7o	28	62	's	's	POS
cord-294438-btuxeq7o	28	63	latest	late	JJS
cord-294438-btuxeq7o	28	64	version	version	NN
cord-294438-btuxeq7o	28	65	of	of	IN
cord-294438-btuxeq7o	28	66	diagnosis	diagnosis	NN
cord-294438-btuxeq7o	28	67	and	and	CC
cord-294438-btuxeq7o	28	68	treatment	treatment	NN
cord-294438-btuxeq7o	28	69	guidelines	guideline	NNS
cord-294438-btuxeq7o	28	70	on	on	IN
cord-294438-btuxeq7o	28	71	COVID-19	COVID-19	NNP
cord-294438-btuxeq7o	28	72	[	[	-LRB-
cord-294438-btuxeq7o	28	73	12	12	CD
cord-294438-btuxeq7o	28	74	]	]	-RRB-
cord-294438-btuxeq7o	28	75	.	.	.
cord-294438-btuxeq7o	29	1	Because	because	IN
cord-294438-btuxeq7o	29	2	antieprogrammed	antieprogrammed	JJ
cord-294438-btuxeq7o	29	3	cell	cell	NN
cord-294438-btuxeq7o	29	4	death	death	NN
cord-294438-btuxeq7o	29	5	1	1	CD
cord-294438-btuxeq7o	29	6	(	(	-LRB-
cord-294438-btuxeq7o	29	7	PD-1	PD-1	NNP
cord-294438-btuxeq7o	29	8	)	)	-RRB-
cord-294438-btuxeq7o	29	9	therapy	therapy	NN
cord-294438-btuxeq7o	29	10	has	have	VBZ
cord-294438-btuxeq7o	29	11	been	be	VBN
cord-294438-btuxeq7o	29	12	implicated	implicate	VBN
cord-294438-btuxeq7o	29	13	as	as	RB
cord-294438-btuxeq7o	29	14	useful	useful	JJ
cord-294438-btuxeq7o	29	15	in	in	IN
cord-294438-btuxeq7o	29	16	treatment	treatment	NN
cord-294438-btuxeq7o	29	17	of	of	IN
cord-294438-btuxeq7o	29	18	chronic	chronic	JJ
cord-294438-btuxeq7o	29	19	infections	infection	NNS
cord-294438-btuxeq7o	29	20	[	[	-LRB-
cord-294438-btuxeq7o	29	21	13	13	CD
cord-294438-btuxeq7o	29	22	]	]	-RRB-
cord-294438-btuxeq7o	29	23	,	,	,
cord-294438-btuxeq7o	29	24	a	a	DT
cord-294438-btuxeq7o	29	25	Chinese	chinese	JJ
cord-294438-btuxeq7o	29	26	manufactured	manufacture	VBN
cord-294438-btuxeq7o	29	27	antibody	antibody	NN
cord-294438-btuxeq7o	29	28	,	,	,
cord-294438-btuxeq7o	29	29	camrelizumab	camrelizumab	NNP
cord-294438-btuxeq7o	29	30	,	,	,
cord-294438-btuxeq7o	29	31	is	be	VBZ
cord-294438-btuxeq7o	29	32	being	be	VBG
cord-294438-btuxeq7o	29	33	investigated	investigate	VBN
cord-294438-btuxeq7o	29	34	in	in	IN
cord-294438-btuxeq7o	29	35	patients	patient	NNS
cord-294438-btuxeq7o	29	36	without	without	IN
cord-294438-btuxeq7o	29	37	cancer	cancer	NN
cord-294438-btuxeq7o	29	38	in	in	IN
cord-294438-btuxeq7o	29	39	China	China	NNP
cord-294438-btuxeq7o	29	40	infected	infect	VBN
cord-294438-btuxeq7o	29	41	with	with	IN
cord-294438-btuxeq7o	29	42	COVID-19	COVID-19	NNP
cord-294438-btuxeq7o	29	43	(	(	-LRB-
cord-294438-btuxeq7o	29	44	ChiCTR200002806	chictr200002806	NN
cord-294438-btuxeq7o	29	45	)	)	-RRB-
cord-294438-btuxeq7o	29	46	.	.	.
cord-294438-btuxeq7o	30	1	However	however	RB
cord-294438-btuxeq7o	30	2	,	,	,
cord-294438-btuxeq7o	30	3	whether	whether	IN
cord-294438-btuxeq7o	30	4	the	the	DT
cord-294438-btuxeq7o	30	5	possibility	possibility	NN
cord-294438-btuxeq7o	30	6	of	of	IN
cord-294438-btuxeq7o	30	7	PD-1	PD-1	NNP
cord-294438-btuxeq7o	30	8	inhibitorerelated	inhibitorerelated	JJ
cord-294438-btuxeq7o	30	9	pneumonia	pneumonia	NN
cord-294438-btuxeq7o	30	10	and	and	CC
cord-294438-btuxeq7o	30	11	potential	potential	JJ
cord-294438-btuxeq7o	30	12	risk	risk	NN
cord-294438-btuxeq7o	30	13	of	of	IN
cord-294438-btuxeq7o	30	14	cytokine	cytokine	NN
cord-294438-btuxeq7o	30	15	-	-	HYPH
cord-294438-btuxeq7o	30	16	release	release	NN
cord-294438-btuxeq7o	30	17	syndrome	syndrome	NN
cord-294438-btuxeq7o	30	18	would	would	MD
cord-294438-btuxeq7o	30	19	aggravate	aggravate	VB
cord-294438-btuxeq7o	30	20	underlying	underlie	VBG
cord-294438-btuxeq7o	30	21	infections	infection	NNS
cord-294438-btuxeq7o	30	22	remain	remain	VBP
cord-294438-btuxeq7o	30	23	unknown	unknown	JJ
cord-294438-btuxeq7o	30	24	[	[	-LRB-
cord-294438-btuxeq7o	30	25	14	14	CD
cord-294438-btuxeq7o	30	26	]	]	-RRB-
cord-294438-btuxeq7o	30	27	,	,	,
cord-294438-btuxeq7o	30	28	as	as	IN
cord-294438-btuxeq7o	30	29	does	do	VBZ
cord-294438-btuxeq7o	30	30	the	the	DT
cord-294438-btuxeq7o	30	31	interplay	interplay	NN
cord-294438-btuxeq7o	30	32	here	here	RB
cord-294438-btuxeq7o	30	33	of	of	IN
cord-294438-btuxeq7o	30	34	chemotherapy	chemotherapy	NN
cord-294438-btuxeq7o	30	35	-	-	HYPH
cord-294438-btuxeq7o	30	36	induced	induce	VBN
cord-294438-btuxeq7o	30	37	neutropenia	neutropenia	NN
cord-294438-btuxeq7o	30	38	.	.	.
cord-294438-btuxeq7o	31	1	An	an	DT
cord-294438-btuxeq7o	31	2	artificial	artificial	JJ
cord-294438-btuxeq7o	31	3	intelligence	intelligence	NN
cord-294438-btuxeq7o	31	4	(	(	-LRB-
cord-294438-btuxeq7o	31	5	AI)ederived	ai)ederived	JJ
cord-294438-btuxeq7o	31	6	knowledge	knowledge	NN
cord-294438-btuxeq7o	31	7	graph	graph	NN
cord-294438-btuxeq7o	31	8	indicated	indicate	VBD
cord-294438-btuxeq7o	31	9	that	that	IN
cord-294438-btuxeq7o	31	10	the	the	DT
cord-294438-btuxeq7o	31	11	JAK1	JAK1	NNP
cord-294438-btuxeq7o	31	12	inhibitor	inhibitor	NN
cord-294438-btuxeq7o	31	13	baricitinib	baricitinib	NN
cord-294438-btuxeq7o	31	14	may	may	MD
cord-294438-btuxeq7o	31	15	help	help	VB
cord-294438-btuxeq7o	31	16	in	in	IN
cord-294438-btuxeq7o	31	17	preventing	prevent	VBG
cord-294438-btuxeq7o	31	18	viral	viral	JJ
cord-294438-btuxeq7o	31	19	entry	entry	NN
cord-294438-btuxeq7o	31	20	via	via	IN
cord-294438-btuxeq7o	31	21	inhibition	inhibition	NN
cord-294438-btuxeq7o	31	22	of	of	IN
cord-294438-btuxeq7o	31	23	clathrin	clathrin	NN
cord-294438-btuxeq7o	31	24	-	-	HYPH
cord-294438-btuxeq7o	31	25	mediated	mediate	VBN
cord-294438-btuxeq7o	31	26	endocytosis	endocytosis	NN
cord-294438-btuxeq7o	31	27	[	[	-LRB-
cord-294438-btuxeq7o	31	28	15	15	CD
cord-294438-btuxeq7o	31	29	]	]	-RRB-
cord-294438-btuxeq7o	31	30	,	,	,
cord-294438-btuxeq7o	31	31	as	as	RB
cord-294438-btuxeq7o	31	32	well	well	RB
cord-294438-btuxeq7o	31	33	as	as	IN
cord-294438-btuxeq7o	31	34	inhibiting	inhibit	VBG
cord-294438-btuxeq7o	31	35	downstream	downstream	JJ
cord-294438-btuxeq7o	31	36	cytokines	cytokine	NNS
cord-294438-btuxeq7o	31	37	[	[	-LRB-
cord-294438-btuxeq7o	31	38	16	16	CD
cord-294438-btuxeq7o	31	39	]	]	-RRB-
cord-294438-btuxeq7o	32	1	;	;	:
cord-294438-btuxeq7o	32	2	it	-PRON-	PRP
cord-294438-btuxeq7o	32	3	is	be	VBZ
cord-294438-btuxeq7o	32	4	notable	notable	JJ
cord-294438-btuxeq7o	32	5	that	that	IN
cord-294438-btuxeq7o	32	6	those	those	DT
cord-294438-btuxeq7o	32	7	data	datum	NNS
cord-294438-btuxeq7o	32	8	revealed	reveal	VBD
cord-294438-btuxeq7o	32	9	a	a	DT
cord-294438-btuxeq7o	32	10	number	number	NN
cord-294438-btuxeq7o	32	11	of	of	IN
cord-294438-btuxeq7o	32	12	tyrosine	tyrosine	NN
cord-294438-btuxeq7o	32	13	kinase	kinase	NN
cord-294438-btuxeq7o	32	14	inhibitors	inhibitor	NNS
cord-294438-btuxeq7o	32	15	as	as	IN
cord-294438-btuxeq7o	32	16	being	be	VBG
cord-294438-btuxeq7o	32	17	potentially	potentially	RB
cord-294438-btuxeq7o	32	18	useful	useful	JJ
cord-294438-btuxeq7o	32	19	too	too	RB
cord-294438-btuxeq7o	32	20	,	,	,
cord-294438-btuxeq7o	32	21	but	but	CC
cord-294438-btuxeq7o	32	22	the	the	DT
cord-294438-btuxeq7o	32	23	authors	author	NNS
cord-294438-btuxeq7o	32	24	immediately	immediately	RB
cord-294438-btuxeq7o	32	25	considered	consider	VBD
cord-294438-btuxeq7o	32	26	them	-PRON-	PRP
cord-294438-btuxeq7o	32	27	too	too	RB
cord-294438-btuxeq7o	32	28	toxic	toxic	JJ
cord-294438-btuxeq7o	32	29	.	.	.
cord-294438-btuxeq7o	33	1	The	the	DT
cord-294438-btuxeq7o	33	2	identification	identification	NN
cord-294438-btuxeq7o	33	3	of	of	IN
cord-294438-btuxeq7o	33	4	effective	effective	JJ
cord-294438-btuxeq7o	33	5	interventions	intervention	NNS
cord-294438-btuxeq7o	33	6	for	for	IN
cord-294438-btuxeq7o	33	7	patients	patient	NNS
cord-294438-btuxeq7o	33	8	with	with	IN
cord-294438-btuxeq7o	33	9	cancer	cancer	NN
cord-294438-btuxeq7o	33	10	infected	infect	VBN
cord-294438-btuxeq7o	33	11	with	with	IN
cord-294438-btuxeq7o	33	12	COVID-19	COVID-19	NNP
cord-294438-btuxeq7o	33	13	remains	remain	VBZ
cord-294438-btuxeq7o	33	14	a	a	DT
cord-294438-btuxeq7o	33	15	major	major	JJ
cord-294438-btuxeq7o	33	16	challenge	challenge	NN
cord-294438-btuxeq7o	33	17	.	.	.
cord-294438-btuxeq7o	34	1	Given	give	VBN
cord-294438-btuxeq7o	34	2	the	the	DT
cord-294438-btuxeq7o	34	3	available	available	JJ
cord-294438-btuxeq7o	34	4	knowledge	knowledge	NN
cord-294438-btuxeq7o	34	5	of	of	IN
cord-294438-btuxeq7o	34	6	possible	possible	JJ
cord-294438-btuxeq7o	34	7	mechanisms	mechanism	NNS
cord-294438-btuxeq7o	34	8	,	,	,
cord-294438-btuxeq7o	34	9	clinical	clinical	JJ
cord-294438-btuxeq7o	34	10	trials	trial	NNS
cord-294438-btuxeq7o	34	11	of	of	IN
cord-294438-btuxeq7o	34	12	drugs	drug	NNS
cord-294438-btuxeq7o	34	13	are	be	VBP
cord-294438-btuxeq7o	34	14	still	still	RB
cord-294438-btuxeq7o	34	15	warranted	warrant	VBN
cord-294438-btuxeq7o	34	16	and	and	CC
cord-294438-btuxeq7o	34	17	individuals	individual	NNS
cord-294438-btuxeq7o	34	18	with	with	IN
cord-294438-btuxeq7o	34	19	cancer	cancer	NN
cord-294438-btuxeq7o	34	20	should	should	MD
cord-294438-btuxeq7o	34	21	be	be	VB
cord-294438-btuxeq7o	34	22	studied	study	VBN
cord-294438-btuxeq7o	34	23	.	.	.
cord-294438-btuxeq7o	35	1	Cancer	cancer	NN
cord-294438-btuxeq7o	35	2	patients	patient	NNS
cord-294438-btuxeq7o	35	3	in	in	IN
cord-294438-btuxeq7o	35	4	SARS	SARS	NNP
cord-294438-btuxeq7o	35	5	-	-	HYPH
cord-294438-btuxeq7o	35	6	CoV-2	CoV-2	NNP
cord-294438-btuxeq7o	35	7	infection	infection	NN
cord-294438-btuxeq7o	35	8	:	:	:
cord-294438-btuxeq7o	35	9	a	a	DT
cord-294438-btuxeq7o	35	10	nationwide	nationwide	JJ
cord-294438-btuxeq7o	35	11	analysis	analysis	NN
cord-294438-btuxeq7o	35	12	in	in	IN
cord-294438-btuxeq7o	35	13	China	China	NNP
cord-294438-btuxeq7o	35	14	Radiological	Radiological	NNP
cord-294438-btuxeq7o	35	15	findings	finding	NNS
cord-294438-btuxeq7o	35	16	from	from	IN
cord-294438-btuxeq7o	35	17	81	81	CD
cord-294438-btuxeq7o	35	18	patients	patient	NNS
cord-294438-btuxeq7o	35	19	with	with	IN
cord-294438-btuxeq7o	35	20	COVID-19	covid-19	JJ
cord-294438-btuxeq7o	35	21	pneumonia	pneumonia	NN
cord-294438-btuxeq7o	35	22	in	in	IN
cord-294438-btuxeq7o	35	23	Wuhan	Wuhan	NNP
cord-294438-btuxeq7o	35	24	,	,	,
cord-294438-btuxeq7o	35	25	China	China	NNP
cord-294438-btuxeq7o	35	26	:	:	:
cord-294438-btuxeq7o	35	27	a	a	DT
cord-294438-btuxeq7o	35	28	descriptive	descriptive	JJ
cord-294438-btuxeq7o	35	29	study	study	NN
cord-294438-btuxeq7o	36	1	The	the	DT
cord-294438-btuxeq7o	36	2	treatment	treatment	NN
cord-294438-btuxeq7o	36	3	and	and	CC
cord-294438-btuxeq7o	36	4	outcome	outcome	NN
cord-294438-btuxeq7o	36	5	of	of	IN
cord-294438-btuxeq7o	36	6	a	a	DT
cord-294438-btuxeq7o	36	7	lung	lung	NN
cord-294438-btuxeq7o	36	8	cancer	cancer	NN
cord-294438-btuxeq7o	36	9	patient	patient	NN
cord-294438-btuxeq7o	36	10	infected	infect	VBN
cord-294438-btuxeq7o	36	11	with	with	IN
cord-294438-btuxeq7o	36	12	SARS	SARS	NNP
cord-294438-btuxeq7o	36	13	-	-	HYPH
cord-294438-btuxeq7o	36	14	CoV-2	CoV-2	NNP
cord-294438-btuxeq7o	36	15	Hepatitis	Hepatitis	NNP
cord-294438-btuxeq7o	36	16	B	B	NNP
cord-294438-btuxeq7o	36	17	reactivation	reactivation	NN
cord-294438-btuxeq7o	36	18	during	during	IN
cord-294438-btuxeq7o	36	19	combination	combination	NN
cord-294438-btuxeq7o	36	20	chemotherapy	chemotherapy	NN
cord-294438-btuxeq7o	36	21	for	for	IN
cord-294438-btuxeq7o	36	22	AIDS	AIDS	NNP
cord-294438-btuxeq7o	36	23	-	-	HYPH
cord-294438-btuxeq7o	36	24	related	relate	VBN
cord-294438-btuxeq7o	36	25	lymphoma	lymphoma	NN
cord-294438-btuxeq7o	36	26	is	be	VBZ
cord-294438-btuxeq7o	36	27	uncommon	uncommon	JJ
cord-294438-btuxeq7o	36	28	and	and	CC
cord-294438-btuxeq7o	36	29	does	do	VBZ
cord-294438-btuxeq7o	36	30	not	not	RB
cord-294438-btuxeq7o	36	31	adversely	adversely	RB
cord-294438-btuxeq7o	36	32	affect	affect	VB
cord-294438-btuxeq7o	36	33	outcome	outcome	NN
cord-294438-btuxeq7o	37	1	A	a	DT
cord-294438-btuxeq7o	37	2	pneumonia	pneumonia	NN
cord-294438-btuxeq7o	37	3	outbreak	outbreak	NN
cord-294438-btuxeq7o	37	4	associated	associate	VBN
cord-294438-btuxeq7o	37	5	with	with	IN
cord-294438-btuxeq7o	37	6	a	a	DT
cord-294438-btuxeq7o	37	7	new	new	JJ
cord-294438-btuxeq7o	37	8	coronavirus	coronavirus	NN
cord-294438-btuxeq7o	37	9	of	of	IN
cord-294438-btuxeq7o	37	10	probable	probable	JJ
cord-294438-btuxeq7o	37	11	bat	bat	NN
cord-294438-btuxeq7o	37	12	origin	origin	NN
cord-294438-btuxeq7o	38	1	Two	two	CD
cord-294438-btuxeq7o	38	2	things	thing	NNS
cord-294438-btuxeq7o	38	3	about	about	IN
cord-294438-btuxeq7o	38	4	COVID-19	COVID-19	NNP
cord-294438-btuxeq7o	38	5	might	may	MD
cord-294438-btuxeq7o	38	6	need	need	VB
cord-294438-btuxeq7o	38	7	attention	attention	NN
cord-294438-btuxeq7o	39	1	SARS	SARS	NNP
cord-294438-btuxeq7o	39	2	-	-	HYPH
cord-294438-btuxeq7o	39	3	CoV-2	CoV-2	NNP
cord-294438-btuxeq7o	39	4	transmission	transmission	NN
cord-294438-btuxeq7o	39	5	in	in	IN
cord-294438-btuxeq7o	39	6	cancer	cancer	NN
cord-294438-btuxeq7o	39	7	patients	patient	NNS
cord-294438-btuxeq7o	39	8	of	of	IN
cord-294438-btuxeq7o	39	9	a	a	DT
cord-294438-btuxeq7o	39	10	tertiary	tertiary	JJ
cord-294438-btuxeq7o	39	11	hospital	hospital	NN
cord-294438-btuxeq7o	39	12	in	in	IN
cord-294438-btuxeq7o	39	13	Wuhan	Wuhan	NNP
cord-294438-btuxeq7o	39	14	Clinical	Clinical	NNP
cord-294438-btuxeq7o	39	15	features	feature	NNS
cord-294438-btuxeq7o	39	16	of	of	IN
cord-294438-btuxeq7o	39	17	patients	patient	NNS
cord-294438-btuxeq7o	39	18	infected	infect	VBN
cord-294438-btuxeq7o	39	19	with	with	IN
cord-294438-btuxeq7o	39	20	2019	2019	CD
cord-294438-btuxeq7o	39	21	novel	novel	JJ
cord-294438-btuxeq7o	39	22	coronavirus	coronavirus	NN
cord-294438-btuxeq7o	39	23	in	in	IN
cord-294438-btuxeq7o	39	24	Wuhan	Wuhan	NNP
cord-294438-btuxeq7o	39	25	,	,	,
cord-294438-btuxeq7o	39	26	China	China	NNP
cord-294438-btuxeq7o	40	1	On	on	IN
cord-294438-btuxeq7o	40	2	the	the	DT
cord-294438-btuxeq7o	40	3	use	use	NN
cord-294438-btuxeq7o	40	4	of	of	IN
cord-294438-btuxeq7o	40	5	corticosteroids	corticosteroid	NNS
cord-294438-btuxeq7o	40	6	for	for	IN
cord-294438-btuxeq7o	40	7	2019-nCoV	2019-ncov	CD
cord-294438-btuxeq7o	40	8	pneumonia	pneumonia	NN
cord-294438-btuxeq7o	40	9	Clinical	clinical	JJ
cord-294438-btuxeq7o	40	10	evidence	evidence	NN
cord-294438-btuxeq7o	40	11	does	do	VBZ
cord-294438-btuxeq7o	40	12	not	not	RB
cord-294438-btuxeq7o	40	13	support	support	VB
cord-294438-btuxeq7o	40	14	corticosteroid	corticosteroid	NN
cord-294438-btuxeq7o	40	15	treatment	treatment	NN
cord-294438-btuxeq7o	40	16	for	for	IN
cord-294438-btuxeq7o	40	17	2019-nCoV	2019-ncov	CD
cord-294438-btuxeq7o	40	18	lung	lung	NN
cord-294438-btuxeq7o	40	19	injury	injury	NN
cord-294438-btuxeq7o	40	20	Cytokine	cytokine	NN
cord-294438-btuxeq7o	40	21	changes	change	NNS
cord-294438-btuxeq7o	40	22	during	during	IN
cord-294438-btuxeq7o	40	23	rituximab	rituximab	JJ
cord-294438-btuxeq7o	40	24	therapy	therapy	NN
cord-294438-btuxeq7o	40	25	in	in	IN
cord-294438-btuxeq7o	40	26	HIV	HIV	NNP
cord-294438-btuxeq7o	40	27	-	-	HYPH
cord-294438-btuxeq7o	40	28	associated	associate	VBN
cord-294438-btuxeq7o	40	29	multicentric	multicentric	NNP
cord-294438-btuxeq7o	40	30	Castleman	Castleman	NNP
cord-294438-btuxeq7o	40	31	disease	disease	NN
cord-294438-btuxeq7o	40	32	Effective	effective	JJ
cord-294438-btuxeq7o	40	33	treatment	treatment	NN
cord-294438-btuxeq7o	40	34	of	of	IN
cord-294438-btuxeq7o	40	35	severe	severe	JJ
cord-294438-btuxeq7o	40	36	COVID-19	covid-19	JJ
cord-294438-btuxeq7o	40	37	patients	patient	NNS
cord-294438-btuxeq7o	40	38	with	with	IN
cord-294438-btuxeq7o	40	39	tocilizumab	tocilizumab	NNP
cord-294438-btuxeq7o	40	40	Immune	immune	JJ
cord-294438-btuxeq7o	40	41	checkpoints	checkpoint	NNS
cord-294438-btuxeq7o	40	42	and	and	CC
cord-294438-btuxeq7o	40	43	their	-PRON-	PRP$
cord-294438-btuxeq7o	40	44	inhibition	inhibition	NN
cord-294438-btuxeq7o	40	45	in	in	IN
cord-294438-btuxeq7o	40	46	cancer	cancer	NN
cord-294438-btuxeq7o	40	47	and	and	CC
cord-294438-btuxeq7o	40	48	infectious	infectious	JJ
cord-294438-btuxeq7o	40	49	diseases	disease	NNS
cord-294438-btuxeq7o	40	50	Severe	severe	JJ
cord-294438-btuxeq7o	40	51	cytokine	cytokine	NN
cord-294438-btuxeq7o	40	52	release	release	NN
cord-294438-btuxeq7o	40	53	syndrome	syndrome	NN
cord-294438-btuxeq7o	40	54	in	in	IN
cord-294438-btuxeq7o	40	55	a	a	DT
cord-294438-btuxeq7o	40	56	patient	patient	NN
cord-294438-btuxeq7o	40	57	receiving	receive	VBG
cord-294438-btuxeq7o	40	58	PD-1-directed	pd-1-directe	VBN
cord-294438-btuxeq7o	40	59	therapy	therapy	NN
cord-294438-btuxeq7o	40	60	COVID-19	covid-19	NN
cord-294438-btuxeq7o	40	61	:	:	:
cord-294438-btuxeq7o	40	62	combining	combine	VBG
cord-294438-btuxeq7o	40	63	antiviral	antiviral	JJ
cord-294438-btuxeq7o	40	64	and	and	CC
cord-294438-btuxeq7o	40	65	anti	anti	JJ
cord-294438-btuxeq7o	40	66	-	-	JJ
cord-294438-btuxeq7o	40	67	inflammatory	inflammatory	JJ
cord-294438-btuxeq7o	40	68	treatments	treatment	NNS
cord-294438-btuxeq7o	40	69	Baricitinib	Baricitinib	NNP
cord-294438-btuxeq7o	40	70	as	as	IN
cord-294438-btuxeq7o	40	71	potential	potential	JJ
cord-294438-btuxeq7o	40	72	treatment	treatment	NN
cord-294438-btuxeq7o	40	73	for	for	IN
cord-294438-btuxeq7o	40	74	2019-nCoV	2019-ncov	CD
cord-294438-btuxeq7o	40	75	acute	acute	JJ
cord-294438-btuxeq7o	40	76	respiratory	respiratory	JJ
cord-294438-btuxeq7o	40	77	disease	disease	NN